Next Article in Journal
Cutaneous Alternariosis Caused by Alternaria infectoria: Three Cases in Kidney Transplant Patients
Previous Article in Journal
B-Mode Ultrasound Imaging, Doppler Imaging, and Real-Time Elastography in Cutaneous Malignant Melanoma and Lymph Node Metastases
Article Menu

Export Article

Open AccessCase Report
Healthcare 2013, 1(1), 96-99; https://doi.org/10.3390/healthcare1010096

Scalp In-Transit Metastatic Melanoma Treated with Interleukin-2 and Pulsed Dye Laser

Department of Dermatology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
*
Author to whom correspondence should be addressed.
Received: 20 August 2013 / Revised: 16 October 2013 / Accepted: 21 October 2013 / Published: 25 October 2013
Full-Text   |   PDF [593 KB, uploaded 25 October 2013]   |  

Abstract

No particular regimen is considered standard therapy for widespread metastatic melanoma, although surgery is the primary choice for regional nodal metastases. Systemic interleukin-2 (IL-2) is an effective immunotherapy for melanoma, but standard doses are associated with severe toxicity. We report a patient who was treated with intralesional low-dose IL-2 and V-beam pulsed dye laser for the treatment of scalp melanoma metastases. This treatment resulted in rapid regression of metastatic tumors with limited adverse effects. View Full-Text
Keywords: interleukin-2; melanoma; pulsed dye laser therapy interleukin-2; melanoma; pulsed dye laser therapy
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Wang, M.Z.; Brewer, J.D. Scalp In-Transit Metastatic Melanoma Treated with Interleukin-2 and Pulsed Dye Laser. Healthcare 2013, 1, 96-99.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Healthcare EISSN 2227-9032 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top